VAlidation of a Lower Cost aneUploidy scrEen

CompletedOBSERVATIONAL
Enrollment

2,443

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

November 19, 2019

Study Completion Date

October 1, 2020

Conditions
Down SyndromeTrisomy 18Trisomy 13
Interventions
OTHER

SmartNIPT

A novel, non-next generation sequencing (NGS) test that is designed to perform as well as conventional NGS screening while being simpler and less expensive.

Trial Locations (16)

15213

Magee Womens Hospital, Pittsburgh

19456

Womens Health Care Group, Oaks

33606

University of South Florida, Tampa

60611

Northwestern Memorial Medical Center, Chicago

77030

University of Texas, Houston

80045

University of Colorado, Aurora

90048

Center for Fetal Medicine, Los Angeles

98104

Swedish Medical Center, Seattle

06610

Bridgeport Hospital, Bridgeport

02110

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

02190

South Shore Hospital, South Weymouth

02905

Women & Infants Hospital of Rhode Island, Providence

M2K 1E1

North York General Hospital, Toronto

G1W IS2

GenoScience Diagnostic, Québec

Unknown

University of Genoa - Hospital San Martino, Genova

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PerkinElmer, Inc.

INDUSTRY

lead

Women and Infants Hospital of Rhode Island

OTHER

NCT03087357 - VAlidation of a Lower Cost aneUploidy scrEen | Biotech Hunter | Biotech Hunter